NIT
ACOR

NumerixS Investment Technologies’s Acorda Therapeutics ACOR Stock Holding History

NumerixS Investment Technologies’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-86
Closed -$30K – 1286
2019
Q3 		$30K Buy
86
+39
+83% +$21.2K 0.01% 835
2019
Q2 		$43K Sell
47
-49
-51% -$60.2K 0.01% 802
2019
Q1 		$152K Buy
96
+53
+123% +$95.5K 0.02% 753
2018
Q4 		$77K Buy
+43
New +$93.6K 0.02% 651
2018
Q3 		– Sell
-32
Closed -$105K – 1415
2018
Q2 		$105K Buy
32
+18
+129% +$55.1K 0.02% 733
2018
Q1 		$40K Buy
+14
New +$41.9K 0.01% 854
2016
Q3 		– Sell
-96
Closed -$293K – 1354
2016
Q2 		$293K Sell
96
-212
-69% -$689K 0.04% 580
2016
Q1 		$976K Buy
+308
New +$1.28M 0.11% 247
2015
Q4 		– Sell
-88
Closed -$281K – 893
2015
Q3 		$281K Buy
+88
New +$341K 0.03% 534
2015
Q2 		– Sell
-165
Closed -$660K – 774
2015
Q1 		$660K Buy
+165
New +$756K 0.12% 236

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

NumerixS Investment Technologies's ACOR Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 86 shares — an estimated $30K sold.

NumerixS Investment Technologies first reported a position in ACOR in Q1 2015 and held it in 10 quarters. The position peaked at $976K in Q1 2016. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • NumerixS Investment Technologies reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 86 Acorda Therapeutics shares in Q4 2019, an estimated $30K.
  • NumerixS Investment Technologies first reported a position in Acorda Therapeutics in Q1 2015 and held it in 10 quarters.
  • NumerixS Investment Technologies's Acorda Therapeutics position peaked at $976K in Q1 2016.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.